KemPharm Completes KP1077 Pre-IND Meeting Process with FDA
KemPharm Positioned to Submit IND Application for KP1077 for Idiopathic Hypersomnia by Mid-2022 CELEBRATION, Fla., Feb. 23, 2022 (GLOBE NEWSWIRE)...
Month: February 2022
Amryt to Report FY and Q4 2021 Results on March 9, 2022
Amryt to Report FY and Q4 2021 Results on March 9, 2022 DUBLIN, Ireland, and Boston MA, February 23, 2022,...
Finch Therapeutics to Participate in the Chardan Metagenomics and Microbiome Medicines Summit
SOMERVILLE, Mass., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage...
Aadi Bioscience Announces U.S. Commercial Launch and Availability of FYARRO™ for the Treatment of Adult Patients with Locally Advanced Unresectable or Metastatic Malignant PEComa
– FYARRO™ added to NCCN® Guidelines as the only preferred mTOR inhibitor to treat malignant PEComa –– PRECISION-1 tumor agnostic...
Algernon Pharmaceuticals Begins Manufacturing of Repirinast and Launches New Chronic Kidney Disease Research Program
VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGWO) (OTCQB:...
BioCryst Reports Fourth Quarter and Full Year 2021 Financial Results and Upcoming Key Milestones
— Q4 2021 ORLADEYO net revenue of $46.2 million and $122.6 million for FY 2021 — — ORLADEYO net revenue...
Jushi Holdings Inc. Announces Participation in Upcoming Webinar and Conference
BOCA RATON, Fla., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF),...
Recro Reports Progress Towards Launching Fill/Finish and Lyophilization Capabilities at San Diego Facility
Full Scope of New Service Capabilities to be Operational in Q2; Company Has Already Secured Project Commitments from Multiple New...
Vancouver discovery will make ‘Magic Mushroom’ mental health care cheaper
Breakthrough process designed by Vancouver scientists uses bacteria as factories to make Psilocybin for psychedelic assisted therapies to treat depression,...
G1 Therapeutics Provides Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
- Achieved $5.8 Million in Total Revenue in the Fourth Quarter of 2021, Including $4.4 Million in Net Revenue from...
Teleflex Receives FDA Clearance for Expanded Indication for Specialty Catheter and Coronary Guidewire Use in CTO PCI Procedures
Results of CTO-PCI IDE Study Demonstrate Procedural Success with Teleflex Specialty Catheters and Coronary Guidewires in Patients Undergoing Chronic Total...
Integra LifeSciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides 2022 Financial Guidance
PRINCETON, N.J., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the...
RadNet, Inc. Announces Date of its Fourth Quarter 2021 Financial Results Conference Call
LOS ANGELES, Feb. 23, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic...
New Ipsos Poll Reveals 26% of Canadians May Soon Need Charitable Services to Meet Basic Needs, Up from 11% Due to Pandemic and Inflation
With 74% of Canadians concerned about inflation and 25% planning to give less to charities in 2022, CanadaHelps renews its...
Sanofi and GSK to seek regulatory authorization for COVID-19 vaccine
Sanofi and GSK to seek regulatory authorization for COVID-19 vaccine * Final analysis of the global VAT02 booster trial confirms...
Sanofi and GSK to seek regulatory authorization for COVID-19 vaccine
Sanofi and GSK to seek regulatory authorization for COVID-19 vaccine * Final analysis of the global VAT02 booster trial confirms...
Mycrodose Therapeutics Granted DEA and FDA Approval to Cultivate Psilocybin Mushrooms in the United States
DEA approval allows Mycrodose Therapeutics to become the first vertically integrated US Pharmaceutical company utilizing psilocybin-based psychedelic medicine. Approval also...
Therma Bright Receives Patent for a Device for Applying a Topical Treatment from U.S. Patent & Trademark Office (USPTO)
Toronto, Ontario--(Newsfile Corp. - February 23, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer...
MEDITECH’s Helen Waters Named EVP and Chief Operating Officer
MEDITECH announces Helen Waters has been promoted to Chief Operating Officer, alongside her current role as Executive Vice President WESTWOOD,...
STORE Capital Appoints David Edwards and Jawad Ahsan to its Board of Directors
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--STORE Capital Corporation (NYSE: STOR), an internally managed net-lease real estate investment trust (REIT) that invests in Single...